Skip to main content
Log in

Tumoren des unteren Gastrointestinaltrakts

Indikation und Ausmaß der Lymphknotendissektion

Tumors of the lower gastrointestinal tract

Indication and extent of lymph node dissection

  • Leitthema
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Die Indikation zur Lymphknotendissektion ist bei der Behandlung fortgeschrittener kolorektaler Karzinome in kurativer Intention fast immer gegeben. Allein für ein adäquates Staging sollten mindestens 12 regionäre Lymphknoten untersucht werden. Das Ausmaß und die Qualität der Lymphknotendissektion haben einen erheblichen Einfluss auf die Langzeitprognose der Patienten, sowohl hinsichtlich lokoregionärer Rezidive als auch bezüglich des Langzeitüberlebens. Das Ausmaß der Lymphknotendissektion hängt grundsätzlich vom Verlauf der vom tumortragenden Darmabschnitt nach zentral ziehenden Gefäßarkaden ab und bestimmt das Resektionsausmaß. Weitere wichtige Prinzipien sind die zentrale Unterbindung der versorgenden Gefäße an den Stammgefäßen, die Erhaltung der autonomen Nerven am Stamm der A. mesenterica superior und der Aorta sowie die Bewahrung der Integrität des Mesokolons bzw. Mesorektums. Die Anzahl der untersuchten und der befallenen regionären Lymphknoten hat einen wesentlichen Einfluss auf die Prognose. Auch bei Dünndarmkarzinomen und den meisten neuroendokrinen Tumoren/Karzinomen wird eine systematische Lymphknotendissektion empfohlen. Bei den gastrointestinalen Stromatumoren ist sie meistens unnötig.

Abstract

Lymph node dissection is almost always indicated in the treatment of advanced colorectal carcinoma with curative intent. Investigation of at least 12 regional lymph nodes is required for adequate staging. The extent and quality of lymph node dissection influence the long-term prognosis, especially locoregional recurrences and long-term survival. The extent of lymphadenectomy depends on the tumour site and the pattern of potential lymphatic spread following the course of the blood vessels supplying the tumour. Important principles are central ligation of the supplying arteries and draining veins right at their roots, preservation of autonomous nerves at the trunk of the superior mesenteric artery and the aorta and preservation of the integrity of the mesocolon or mesorectum. The number of regional lymph nodes examined as well as the number of lymph nodes with metastases influence the prognosis. Systematic lymph node dissection is also recommended for carcinomas of the small bowel and in most neuroendocrine tumours or carcinomas but is not required for gastro-intestinal stromal tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Abrahams NA, Halverson A, Fazio VW et al (2002) Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 45:1496–1502

    Article  PubMed  Google Scholar 

  2. Andtbacka RH, Ng CS, Scaife CL et al (2007) Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14:14–24

    Article  PubMed  Google Scholar 

  3. Belli F, Gallino GF, Lo Vullo S et al (2009) Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol 35:757–762

    CAS  PubMed  Google Scholar 

  4. Bundesverband Deutscher Pathologen e.V. und Deutsche Gesellschaft für Pathologie e.V. (2005) Version 1.0 Empfehlungen zur pathologisch-anatomischen Diagnostik des kolorektalen Karzinoms. Erhältlich über: http://www.bv-pathologie.de/mitgliederbereich/download.php?f=leitlinie_kolo_karzinom.pdf

  5. Bittner R, Burghardt J, Gross E et al (2007) Qualitätsindikatoren der Diagnostik und Therapie des Rektumkarzinoms. Zentralbl Chir 132:85–94

    Article  CAS  PubMed  Google Scholar 

  6. Blay JY, Bonvalot S, Casali P et al (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol 16:566–578

    Article  PubMed  Google Scholar 

  7. Cahill RA (2007) What’s wrong with sentinel node mapping in colon cancer? World J Gastroenterol 13:6291–6294

    Article  PubMed  Google Scholar 

  8. Chang GJ, Rodriguez-Bigas MA, Skibber JM et al (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441

    Article  PubMed  Google Scholar 

  9. Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244:602–610

    PubMed  Google Scholar 

  10. Dabaja BS, Suki D, Pro B et al (2004) Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101:518–526

    Article  PubMed  Google Scholar 

  11. Damin DC, Rosito MA, Schwartsmann G (2006) Sentinel lymph node in carcinoma of the anal canal: a review. Eur J Surg Oncol 32:247–252

    Article  CAS  PubMed  Google Scholar 

  12. Daum S, Ullrich R, Heise W (2003) Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol 21:2740–2746

    Article  PubMed  Google Scholar 

  13. Dillman RO, Aaron K, Heinemann FS et al (2009) Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer 115:1840–1848

    Article  PubMed  Google Scholar 

  14. Doekhie FS, Mesker WE, Kuppen PJ et al (2009) Detailed examination of lymph nodes improves prognostication in colorectal cancer. Int J Cancer [Epub ahead of print]

  15. Ducreux M, Boutron MC, Piard F et al (1998) A 15-year series of gastrointestinal non-Hodgkin’s lymphomas: a population-based study. Br J Cancer 77:511–514

    CAS  PubMed  Google Scholar 

  16. Earle CC, Weiser MR, Ter Veer A et al (2009) Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol [Epub ahead of print]

  17. Fischbach W (2004) Gastrointestinale Lymphome. Z Gastroenterol 42:1067–1072

    Article  CAS  PubMed  Google Scholar 

  18. Fornaro R, Picori E, Stabilini C et al (2006) Carcinoid tumors of the appendix: when right colectomy? G Chir 27:233–239

    CAS  PubMed  Google Scholar 

  19. Gervaz P, Huber O, Morel P (2009) Surgical management of gastrointestinal stromal tumours. Br J Surg 96:567–578

    Article  CAS  PubMed  Google Scholar 

  20. Giedl J (1986) Lymphknotenmetastasen kolorektaler Karzinome. Häufigkeit und Topographie. Fortschr Med 104:167–170

    CAS  PubMed  Google Scholar 

  21. Hermanek P (2000) Lymphknoten und maligne Tumorkrankheit. Zentralbl Chir 125:790–795

    Article  CAS  PubMed  Google Scholar 

  22. Hida J, Yasutomi M, Fujimoto K et al (1997) Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. J Am Coll Surg 184:475–480

    CAS  PubMed  Google Scholar 

  23. Hölzel D, Engel J, Löhrs U (2008) Sind elektive Lymphknotendissektionen in der Karzinomchirurgie noch zeitgemäß? Zentralbl Chir 133:582–589

    Article  PubMed  Google Scholar 

  24. Hölzel D, Eckel R, Engel J (2009) Metastasierung beim kolorektalen Karzinom. Häufigkeiten, Prognose und Folgerungen. Chirurg 80:331–340

    Article  PubMed  Google Scholar 

  25. Hohenberger P, Wardelmann E (2006) Gastrointestinale Stromatumoren. Was der Chirurg wissen muss. Chirurg 77:33–40

    Article  CAS  PubMed  Google Scholar 

  26. Hohenberger W, Merkel S, Weber K (2007) Lymphadenektomie bei Tumoren des unteren Gastrointestinaltrakts. Chirurg 78:217–225

    Article  CAS  PubMed  Google Scholar 

  27. Hohenberger W (2007) Offene Rektumchirurgie. Chirurg 78:739–747

    Article  CAS  PubMed  Google Scholar 

  28. Hohenberger W, Weber K, Matzel K et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome. Colorectal Dis 11:354–365

    Article  CAS  PubMed  Google Scholar 

  29. Howe JR, Karnell LH, Menck HR et al (1999) The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985–1995. Cancer 86:2693–2706

    Article  CAS  PubMed  Google Scholar 

  30. Jinnai D (1983) General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum. Jpn J Surg 13:557–573

    Article  Google Scholar 

  31. Kelder W, Inberg B, Schaapveld M et al (2009) Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands. Dis Colon Rectum 52:260–267

    PubMed  Google Scholar 

  32. Kikuchi R, Takano M, Takagi K et al (1995) Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286–1295

    Article  CAS  PubMed  Google Scholar 

  33. Kim YW, Kim NK, Min BS et al (2009) The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg 249:965–972

    Article  PubMed  Google Scholar 

  34. Kim YW, Kim NK, Min BS et al (2009) The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol 100:1–7

    Article  CAS  PubMed  Google Scholar 

  35. Kim YS, Kim JH, Yoon SM et al (2009) Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys 74:796–802

    PubMed  Google Scholar 

  36. Köckerling F, Reymond MA, Altendorf-Hofmann A et al (1998) Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 16:324–329

    PubMed  Google Scholar 

  37. Landry CS, Brock G, Scoggins CR et al (2008) Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg 207:874–881

    Article  PubMed  Google Scholar 

  38. Le Voyer TE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919

    Article  Google Scholar 

  39. Lopez-Kostner F, Lavery IC, Hool GR et al (1998) Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 124:612–618

    Article  CAS  PubMed  Google Scholar 

  40. Matzel KE, Merkel S, Hohenberger W (2003) Lokale Therapieprinzipien beim Rektumkarzinom. Chirurg 74:897–904

    Article  CAS  PubMed  Google Scholar 

  41. Merkel S, Klossek D, Göhl J et al (2009) Quality management in rectal carcinoma: what is feasible? Int J Colorectal Dis 24:931–942

    Article  PubMed  Google Scholar 

  42. Modlin IM, Kidd M, Latich I et al (2005) Current status of gastrointestinal carcinoids. Gastroenterology 128:1717–1751

    Article  PubMed  Google Scholar 

  43. Nagtegaal ID, Velde CJH van de, Worp E van der et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734

    Article  PubMed  Google Scholar 

  44. Nascimbeni R, Burgart LJ, Nivatvongs S et al (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200–206

    Article  PubMed  Google Scholar 

  45. Nicholl MB, Wright BE, Conway WC et al (2009) Does specialized surgical training increase lymph node yield in colon cancer? Am Surg 75:887–891

    PubMed  Google Scholar 

  46. Nilsson PJ, Svensson G, Goldman S et al (2005) Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 61:92–102

    PubMed  Google Scholar 

  47. Olsha O, Mintz A, Gimon Z et al (2005) Anal melanoma in the era of sentinel lymph node mapping: a diagnostic and therapeutic challenge. Tech Coloproctol 9:60–62

    Article  CAS  PubMed  Google Scholar 

  48. Parfitt JR, Driman DK (2007) The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol 60:849–855

    Article  PubMed  Google Scholar 

  49. Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 248:968–978

    Article  PubMed  Google Scholar 

  50. Scherübl H, Klöppel G (2009) Neuroendokrine Neoplasien des Rektums auf dem Vormarsch – ein Update. Z Gastroenterol 47:365–371

    Article  PubMed  Google Scholar 

  51. Sobin LH, Wittekind CH (eds) UICC (2002) TNM classification of malignant tumours, 6th edn. John Wiley & Sons, Inc., New York

  52. Sobin LH, Gospodarowicz M, Wittekind CH (eds) UICC (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, New York

  53. Sutton R, Doran HE, Williams EM et al (2003) Surgery for midgut carcinoid. Endocr Relat Cancer 10:469–481

    Article  CAS  PubMed  Google Scholar 

  54. Swanson RS, Compton CC, Stewart AK et al (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71

    Article  PubMed  Google Scholar 

  55. Tran T, Davila JA, El-Serag HB (2005) The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100:162–168

    Article  PubMed  Google Scholar 

  56. Vaccaro CA, Im V, Rossi GL et al (2009) Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 52:1244–1250

    PubMed  Google Scholar 

  57. Vather R, Sammour T, Zargar-Shoshtari K et al (2009) Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer. Int J Colorectal Dis 24:283–288

    Article  PubMed  Google Scholar 

  58. Veyrières M, Baillet P, Hay JM et al (1997) Factors influencing long-term survival in 100 cases of small intestine primary adenocarcinoma. Am J Surg 173:237–239

    Article  PubMed  Google Scholar 

  59. West NP, Morris EJ, Rotimi O et al (2008) Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 9:857–865

    Article  PubMed  Google Scholar 

  60. West NP, Hohenberger W, Weber K et al (2009) Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol in press

  61. Westdeutsches Darm-Centrum GmbH, Benchmarking Darmzentren WDC, Jahresbericht (2008) Erhältlich über: http://www.darm-centrum.de/doc/controls/document/docrender.aspx?ID=107

  62. Wittekind CH, Greene FL, Henson DE et al (eds) UICC (2003) TNM Supplement. A commentary on uniform use. 3rd edn. Wiley-Liss, New York

  63. Wu TJ, Yeh CN, Chao TC et al (2006) Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg 30:391–399

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Hohenberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merkel, S., Weber, K., Perrakis, A. et al. Tumoren des unteren Gastrointestinaltrakts. Chirurg 81, 117–126 (2010). https://doi.org/10.1007/s00104-009-1814-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-009-1814-9

Schlüsselwörter

Keywords

Navigation